Shanghai Pharmaceuticals' Clevidipine Injectable Emulsion Approved for Production

证券时报··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Shanghai Pharmaceuticals announced on October 9 that its subsidiary Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd. received the Drug Registration Certificate for Clevidipine Injectable Emulsion from the National Medical Products Administration, and the drug has been approved for production. Clevidipine Injectable Emulsion is mainly used to treat hypertension in patients for whom oral medication is unsuitable or expected to be ineffective.

Impact on assets 1

Others▲

Off-coverage companies 1

Shanghai SPH First Biochemical Pharmaceutical Co Ltdi
Private▲ PositiveRegulationrelevance

The subsidiary itself received the Drug Registration Certificate and production approval for Clevidipine Injectable Emulsion.